Bell Potter biotech analyst Linda Ong rated the stock a "buy two", upgrading its valuation to $1.57, after the stock went into a trading halt late last week at 68¢.
Avexa, which has more than doubled its share price this year, is expected to return to trading tomorrow after it has finalised the terms of its capital raising.
- Forums
- ASX - By Stock
- AVX
- smh tues 20th
smh tues 20th, page-3
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)